886 Combined allogeneic NK cell and Herzuma® is effective in HER2-low breast cancer preclinical model by enhancing antibody-dependent cellular cytotoxicity
العنوان: | 886 Combined allogeneic NK cell and Herzuma® is effective in HER2-low breast cancer preclinical model by enhancing antibody-dependent cellular cytotoxicity |
---|---|
المؤلفون: | Yong Moon, Mithun Gosh, Hee-Jung An, Tae Hoen Kim, Sa Deok Hong, Nar Bahadur Katuwal, Minsil Kang |
المصدر: | Regular and Young Investigator Award Abstracts. |
بيانات النشر: | BMJ Publishing Group Ltd, 2022. |
سنة النشر: | 2022 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::321d7445d803536eb8a88fae25258461 https://doi.org/10.1136/jitc-2022-sitc2022.0886 |
رقم الأكسشن: | edsair.doi...........321d7445d803536eb8a88fae25258461 |
قاعدة البيانات: | OpenAIRE |
الوصف غير متاح. |